Our study aimed to assess the diagnostic accuracy of anti-cN1A in a cohort of patients who underwent a myositis line immunoassay for suspected idiopathic inflammatory myopathies (IIM). This evidence concerns the gene NT5C1A and acquired idiopathic inflammatory myopathy.